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Elucidating the mechanisms underlying hematopoi-
etic stem cell (HSC) specification and expansion in
the embryo has been hampered by the lack of analyt-
ical cell culture systems that recapitulate in vivo de-
velopment. Here, we describe an ex vivo model that
facilitates a rapid and robust emergence of multipo-
tent long-term repopulating HSCs in the embryonic
AGM region. Because this method includes a cell
dissociation step prior to reconstruction of a three-
dimensional functional tissue and preserves both
stromal and hematopoietic elements, it allowed us
to identify the direct ancestry of the rapidly expand-
ing HSC pool. We demonstrate that extensive
generation of definitive HSCs in the AGM occurs pre-
dominantly through the acquisition of stem charac-
teristics by the VE-cadherin+CD45+ population.
INTRODUCTION
Hematopoietic stem cell (HSC) development during ontogeny is
a complex developmental cascade, the mechanisms of which re-
main poorly understood. Prior to fetal liver colonization, HSCs
emerge in multiple extrahepatic locations between embryonic
days (E) 10.5–11.5 (Gekas et al., 2005; Kumaravelu et al., 2002;
Medvinsky and Dzierzak, 1996; Morrison et al., 1995; Ottersbach
and Dzierzak, 2005). Between E11.5 and E12.5, HSCs are gener-
ated at an extremely high rate: from three to ten HSCs in the en-
tire E11.5 conceptus to 70 to 150 HSCs by E12.5 (Gekas et al.,
2005; Kumaravelu et al., 2002). The mechanism by which this
massive expansion occurs can be explained either by the rapid
proliferation of pre-existing HSCs or by the maturation of HSCs
from as yet unknown ancestor cells (Dzierzak and Medvinsky,
1995; Ferkowicz et al., 2003). Neither transgenic approaches
nor culture techniques described to date have provided a
methodology to discriminate between these alternatives.
The explant culture system has successfully been used in
developmental biology as a tool for dissecting mechanisms of
morphogenesis and differentiation of various organ rudiments
(Moscona and Moscona, 1952b; Shannon and Hyatt, 2004).
Based on this principle, ex vivo culture methods have been de-
signed to study the spatial origins of HSC development in theembryo (Cumano et al., 2001; de Bruijn et al., 2000; Kumaravelu
et al., 2002; Medvinsky and Dzierzak, 1996; Taoudi and Medvin-
sky, 2007). It has been demonstrated that, between E10.5 and
E11.5, the AGM region is capable of an autonomous initiation
and expansion of bona fide definitive HSCs (Medvinsky and
Dzierzak, 1996); this can be enhanced by the addition of exoge-
nous interleukin-3 (Robin et al., 2006). However, the accessibility
of AGM explants for mechanistic analysis is highly restricted.
Therefore, attempts to elucidate developmental cues that under-
lie HSC specification and expansion have focused on the deriva-
tion and use of stromal cell lines. Although these cell lines were
able to maintain adult bone marrow HSCs (Ohneda et al.,
1998; Oostendorp et al., 2002; Xu et al., 1998), they have not
yielded any greater mechanistic insight into the process of
HSC generation.
Classical embryological studies have demonstrated that
a number of dissociated embryonic organs are capable of both
reorganization and continuation along their specified develop-
mental pathways upon reaggregation. Using this approach,
fundamental biological processes within complex organs have
been elucidated (Anderson et al., 1993; Grobstein, 1953; Mos-
cona and Moscona, 1952a; Townes and Holtfreter, 1955; White
et al., 2007). Based on the principle of organ reaggregation, we
developed a robust analytical culture system that facilitates an
unprecedented HSC expansion at a level comparable to that
observed in vivo. Crucially, this system allows controlled manip-
ulation of defined AGM cell populations prior to continued ex
vivo development. Herein, we demonstrate that the VE-cadher-
in+CD45+ fraction of the E11.5 AGM region, which is spatially
restricted to intra-aortic clusters, contains pre-HSCs capable
of rapidly maturing into functional definitive HSCs.
RESULTS
Successful Ex Vivo HSC Maintenance
following Dissociation and Reaggregation
of the E11.5 AGM Region
Previously, attempts to preserve definitive HSC activity in vitro
from a single-cell suspension of E11.5 AGM have been unsuc-
cessful (data not shown). This deficiency has hampered prog-
ress into dissecting the mechanisms of HSC specification and
expansion in primary embryonic hematopoietic organs. To over-
come this obstacle, we made two crucial developments. The first
was to define a medium that could facilitate HSC expansion. TheCell Stem Cell 3, 99–108, July 2008 ª2008 Elsevier Inc. 99
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preservation of HSC activity in the AGM region following disag-
gregation of the organ’s original structure and allow a period of
ex vivo development to be undertaken.
Using IMDM-based medium supplemented with interleukin-3
(IL3), stem cell factor (SCF), and Flt3-ligand (Flt3L) (referred to
as IMDM+ medium), we were able to preserve the ex vivo capac-
ity of the E11.5 AGM region to generate HSCs after dissociation
and reaggregation of the organ (Figure S1 of Supplemental Data
available online). Of note, successful maintenance of stromal el-
ements (including endothelial cells) and HSCs required culture of
dissociated tissues at the gas-liquid interface (Figure S1). HSCs
within the AGM reaggregate were capable of long-term multiline-
age reconstitution (Figure S2) and contributed to the recipient
HSC compartment, as evidenced by successful secondary
transplantations (Figure S3).
During ex vivo development of the reaggregated AGM region,
the hematopoietic (CD45-expressing) compartment underwent
extensive expansion, increasing from 3,640 ± 310 to 32,130 ±
5,960 cells within a 96 hr period (Figures 1A and S4). Functional
examination revealed that a massive expansion of committed
myeloid progenitors (colony-forming units-culture [CFU-C]) and
immature late-developing colony-forming units-spleen (CFU-
S11) had also occurred. Specifically, CFU-Cs expanded 45-fold
(120 ± 15 to 5,440 ± 120) (Figure 1B), and CFU-S11 expanded
230-fold (3.3 ± 2.0 to 770 ± 390) (Figure 1C).
Quantification of HSC Generation
To assess expansion of the HSC compartment, the total num-
bers of HSCs produced in the system were determined in a series
of in vivo transplantation experiments. In line with previous data
(Gekas et al., 2005; Kumaravelu et al., 2002), no more than one
HSC was detected per single uncultured E11.5 AGM region
(one out of four experimental mice were repopulated; Figure 1D).
We then carried out time course experiments to characterize the
temporal kinetics of HSC formation. Between 24 and 48 hr, no
HSC expansion had occurred, since no more than one HSC
per single reaggregate dose was detected (Figure 1D). However,
at 72 and 96 hr of culture, each mouse that received a transplant
of 0.5 dose of reaggregate was repopulated at a high level
(Figure 1D), indicating that HSC expansion occurs in the final
48 hr of culture.
To accurately calculate the absolute number of HSCs present
at 72 and 96 hr of culture in vivo, limiting dilution studies were
performed. These data demonstrated that approximately six
HSCs per reaggregate were present at 72 hr (Figure 1E) and
approximately 150 HSCs per reaggregate at 96 hr (Figure 1F).
Thus, unlike the progenitor compartment that undergoes linear
expansion, the HSC compartment expands exponentially be-
tween 72 and 96 hr of culture, indicating the occurrence of either
a very rapid proliferation of the single pre-existing HSC or a mass
maturation of HSC ancestors (pre-HSCs). Notably, the presence
of all three growth factors (IL3, SCF, and Flt3L) was required to
facilitate a 150-fold expansion of HSCs (Figure S5).
Acquisition of Stem Cell Function Is the Predominant
Mechanism of HSC Generation
Consistent with the observed extensive and rapid production of
hematopoietic cells within AGM reaggregates, we found that, in100 Cell Stem Cell 3, 99–108, July 2008 ª2008 Elsevier Inc.comparison with other lineages, a greater proportion of CD45+
cells were in S phase of cell cycle (Figure S6). These data indi-
cated that rapid proliferation might be a key mechanism for
HSC expansion. Thus, to establish the proliferative history of
stem and progenitor cells, a cellular suspension of E11.5 AGM
was loaded with the dye carboxyfluoroscein diacetate succini-
midyl ester (CFSE). As previously described (Lyons, 1999),
CFSE is distributed between daughter cells at division such
that fluorescence intensity diminishes by half at each mitosis,
allowing the number of divisions to be determined by flow cy-
tometry. At the 96 hr endpoint, the cells present within the reag-
gregate demonstrated a differential retention of CFSE, reflecting
differences in proliferative history during the culture (Figure 2A).
Consistent with the majority of CD45+ cells being in S phase,
most hematopoietic cells retained low to undetectable levels of
CFSE.
We then identified the following CD45+ fractions on the basis
of proliferative history: high proliferating (fraction A, approxi-
mately five to seven divisions), low proliferating (fraction B, ap-
proximately one to four divisions), and nondividing (fraction C,
zero divisions) (Figure 2A). Gating of fraction C was based on
the analysis of reaggregates cultured in the presence of the mi-
totic inhibitor demecolcine, which provided a control for the level
of CFSE expected within nondividing cells (data not shown). All
nonhematopoietic (CD45) lineages were grouped as fraction D.
Fractions A–D were purified by flow cytometry and studied
morphologically and functionally (Figure 2A). Fraction A con-
tained a high frequency of cells with classical blast (stem/pro-
genitor) cell morphology characterized by a high nuclear-to-cy-
toplasmic ratio (Figure 2A). Fraction B also contained blast-like
cells, but a higher frequency of differentiated cells was also
observed. All nonproliferating cells purified from fraction C ap-
peared to have a fully differentiated morphology (Figure 2A).
Cell cycle analysis of fractions A–C after 96 hr demonstrated
that the majority of cells in fraction A were within the active
phases of the cell cycle (Figure 2A). In contrast, the vast majority
of cells in fractions B and C were in the G0/G1 position of the cycle.
Fractions A, B, and C were tested functionally for the contents
of CFU-Cs, upstream immature myeloid CFU-S11, and definitive
HSCs. While nearly all CFU-Cs resided in the highly proliferative
fraction A (Figure 2B), most CFU-S11 and HSCs were contained
within the slowly dividing fraction B (Figures 2C and 2D); only 4
out of 11 recipients were repopulated after receiving a 0.05
dose of fraction A, while all 11 recipients of fraction B were
successfully repopulated (Figure 2D). We estimate that there
are approximately eight HSCs in fraction A with the remaining
140 HSCs residing in fraction B. Thus, the vast majority of
HSCs underwent a limited number of divisions.
Although CFU-S and HSC compartments underwent the
greatest fold increase, 230- and 150-fold, respectively, they un-
derwent fewer divisions than CFU-Cs (Figures 2B–2D). The fact
that the HSCs underwent no more than four divisions is not com-
patible with the idea that they originate from a single parental
HSC. For this to have occurred, a minimum of seven to eight
symmetrical divisions would be required, which would result in
undetectable levels of CFSE. Thus, HSC generation occurs
predominantly via an acquisition of stem cell characteristics by
HSC ancestors (pre-HSCs) rather than by rapid amplification of
a pre-existing single HSC.
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Development of HSCs in the AGM RegionFigure 1. Rapid Ex Vivo HSC Generation in the AGM Region
(A and B) The hematopoietic (CD45+) compartment undergoes extensive expansion during culture, as do all types of CFU-C. Data indicate the numbers of total
CD45+ cells and CFU-Cs per reaggregate (three independent experiments ± SEM).
(C) Expansion of late-developing colony-forming unit-spleen (CFU-S11) after 96 hr (three independent experiments ± SD). The donor origin of spleen colonies was
confirmed using reaggregates produced from EGFP+ embryos (left spleen); no colonies were detected in irradiated control mice (right spleen).
(D) Time course of HSC generation during ex vivo development. At 24, 48, 72, and 96 hr, cells were transplanted; each recipient received a 0.5 dose of reaggre-
gate. Each point represents an individual recipient mouse. Data are cumulative of two independent experiments.
(E and F) Statistical analysis of limiting dilution experiments indicates the presence of approximately six HSCs and 146 HSCs per reaggregate after 72 hr and 96 hr,
respectively.To investigate the spatial aspect of HSC development within
the AGM reaggregate, we first identified the immunophenotype
of the stem cell compartment. To this end, cell fractions gener-
ated within the reaggregate after 96 hr were sorted by flow cy-
tometry on the basis of known stem cell markers and tested in
long-term repopulation experiments. We found that the AGM-
derived HSC population had adopted an adult-like bone marrow
HSC immunophenotype: CD45+cKit+Sca1+PECAM-1lowCD34
phenotype (Figure 3A) (Baumann et al., 2004; Osawa et al.,
1996; Uchida and Weissman, 1992). The lack of CD34 expres-
sion indicates that the fetal liver stage, which involves sustained
CD34 expression (Matsuoka et al., 2001), had been bypassed.
From our CFSE experiments, we estimate that the frequency ofHSCs in fraction B (CD45+CFSElow) is 1 in 80 cells (140 HSCs
in 11,160 total fraction B cells). When Sca1 is also included in
the selecting cocktail, the enrichment for HSCs is increased to
1 in 15 cells, as only 19% ± 3.5% of fraction B cells coexpress
Sca1 (Figure 3B).
This phenotypic analysis allowed us to investigate the spatial
distribution of progenitor and stem cells within the reaggregate
using confocal microscopy (Figure 3C). We found that CFU-C
progenitors (CD45+CFSEneg cells) were located in large colonies
(Figures 3D and 3D0). HSCs (CD45+CFSElowSca1+) were not
found within these same colonies but were located separately ei-
ther in small clusters (Figures 3E and 3E0) or as individual cells
(Figures 3F and 3F0). This observation is consistent with ourCell Stem Cell 3, 99–108, July 2008 ª2008 Elsevier Inc. 101
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Development of HSCs in the AGM RegionFigure 2. Tracing the HSC Proliferative History following AGM Ex Vivo Development
(A) Cell suspension from E11.5 AGM was loaded with carboxyfluoroscein diacetate succinimidyl ester (CFSE) prior to culture. After 96 hr, the expanded hema-
topoietic (CD45+) population was segregated according to proliferative history based on CFSE loss. Fraction A (CFSEnegCD45+) underwent five to seven divi-
sions; fraction B (CFSElowCD45+), one to four divisions; fraction C (CFSEhighCD45+), zero divisions. The majority of nonhematopoietic lineages (fraction D)
underwent approximately one to four divisions. Numbers indicate the numbers of divisions. Contour plot illustrates the placement of gates for fractions A–D;
sorted fractions A–C are shown on cytospin preparations stained with May-Grunwald-Giemsa. The percentages of each fraction per reaggregate are shown
(three independent experiments ± SEM). Cell cycle analysis of fractions A–C. Shown are the percentages of cells in S phase (three independent experiments ±
SEM).
(B) The vast majority of colony-forming units-culture (CFU-C) are restricted to fraction A (three independent experiments ± SEM).
(C) In contrast, nearly all colony-forming units-spleen (CFU-S11) reside in fraction B (two independent experiments ± SD).
(D) The vast majority of HSCs also reside in fraction B. Each dot represents one recipient that had received a 0.05 dose of a respective purified fraction. Data are
cumulative of three independent experiments.conclusion that the pool of HSCs matures from multiple pre-
HSCs via a restricted number of divisions.
The CD45+ Compartment Is the Major Contributor
to HSC Expansion in the AGM Reaggregate
To determine the pre-HSCs’ identities, we investigated whether
hematopoietic (CD45+) or nonhematopoietic (CD45) cells were
capable of developing into HSCs. To this end, CD45+ cells
from wild-type (WT) E11.5 AGM regions were replaced by
MACS-purified CD45+ cells from EGFP E11.5 AGM regions
(Figure 4A). Cells were mixed at the quantitative ratio observed102 Cell Stem Cell 3, 99–108, July 2008 ª2008 Elsevier Inc.in the E11.5 AGM region (135,000 WT CD45 cells and 5,000
EGFP CD45+ cells, i.e., to produce a reaggregate with an initial
cellularity equivalent to one fresh E11.5 AGM) and chimeric
reaggregates were produced. After 96 hr of culture, the vast
majority (95% ± 0.9%) of hematopoietic cells in these chimeric
reaggregates were derived from EGFP CD45+ ancestors
(Figure 4B).
We then traced the lineage ancestry of definitive HSCs by
transplantation of the chimeric reaggregates into irradiated
Ly5.2/1 adult mice and detecting donor-derived cells in the pe-
ripheral blood of recipient mice (Figure 4C). All nine recipient
Cell Stem Cell
Development of HSCs in the AGM Regionmice were reconstituted with EGFP+ HSCs derived from the
CD45+ compartment. Consistent with HSCs generated by WT
reaggregates (Figure S2), EGFP+ cells contributed to both mye-
loid and lymphoid lineages in all tissues tested (data not shown).
Only one recipient mouse also contained donor-derived blood
cells of CD45 ancestry (Figure 4C). Although we were able to
use highly purified CD45 cells, the possibility of contamination
with rare but highly potent CD45+ cells cannot be excluded.
Thus, we conclude that the vast majority of HSCs in the AGM re-
Figure 3. Spatial Compartmentalization of
Stem and Progenitor Cells in the Reaggre-
gated AGM Region
(A) The immunophenotype of HSCs produced af-
ter 96 hr was determined by transplanting defined
cellular populations, purified by flow cytometry,
into irradiated adult mice. Indicated is the number
of reconstituted animals as a fraction of the
total number of recipients. HSCs derived from
the E11.5 AGM region adopt an adult-like
CD45+cKit+Sca1+PECAM-1lowCD34 immuno-
phenotype.
(B) The vast majority of HSCs can be isolated as
CD45+CFSElowSca1+ cells, enriching HSCs to ap-
proximately 1 in 15 cells.
(C) E11.5 AGMs were dissociated, loaded with
CFSE (green), and reaggregated. After 96 hr ex
vivo, the reaggregate was prepared for confocal
microscopy. Sections were stained using anti-
CD45 (red) and anti-Sca1 (blue) antibodies (scale
bar, 70 mm).
(D and D0 ) Areas of CFU-C progenitors
(CD45+CFSEneg) are readily identified.
(E, E0, F, and F0 ) CD45+CFSElowSca1+ (HSCs) are
found segregated either in small clusters or as sin-
gle cells dispersed within the central region of the
reaggregate (scale bar, 37 mm).
(D0–F0) Zooms of boxed regions shown in (D)–(F);
shown are CFSE-retaining HSCs (arrowheads)
and CFSE hematopoietic cells (asterisk). Images
are representative sections from four individual
reaggregates.
aggregate were generated by the matura-
tion of CD45-expressing pre-HSCs.
Pre-HSCs Reside within the
VE-Cadherin+CD45+ Subfraction
of the Hematopoietic Compartment
The first HSC emerging in the AGM bears
a distinctive dual hemato-endothelial
immunophenotype coexpressing both
VE-cadherin and CD45 markers (North
et al., 2002; Taoudi et al., 2005). Among
70 VE-cadherin+CD45+ cells contained
in the E11.5 AGM region, one is a defini-
tive HSC (Figure 1D) (Gekas et al., 2005;
Kumaravelu et al., 2002; Taoudi et al.,
2005). The functional capacity of other
VE-cadherin+CD45+ cells is unclear.
While CD45+ cells are scattered throughout the entire E11.5
AGM region (Figure 5A), cells of the VE-cadherin+CD45+ frac-
tion are intimately associated with the endothelial lining of the
dorsal aorta, represented as cuboid epithelium. They are either
integrated into the endothelial lining (Figures 5B and 5B0) or
they form intra-aortic clusters protruding into the aortic lumen
(Figures 5C and 5C0). We observed that each E11.5 AGM re-
gion typically contains two to four of these intra-aortic clus-
ters. Polarized localization of both CD45 and VE-cadherinCell Stem Cell 3, 99–108, July 2008 ª2008 Elsevier Inc. 103
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nization, consistent with the fact that they originate from the
endothelial lining. In rare cases, solitary VE-cadherin+CD45+
cells are associated with the luminal surface of the endothelial
lining (data not shown).
To investigate whether the VE-cadherin-CD45+ or VE-cadher-
in+CD45+ populations harbor pre-HSCs, we performed further
lineage-tracing experiments. To this end, each population was
purified by flow cytometry from AGM regions dissected from
E11.5 EGFP embryos (Figure 6A) and reaggregated with CD45
cells purified from WT AGM regions (Figure 6B). Following 96 hr
of ex vivo development, only a modest expansion of hematopoi-
etic cells was observed from the VE-cadherinCD45+ population;
from5,000 input cells, 5,530 ± 1,550 CD45+ cells were detected
after culture (Figure 6C). Transplantation of a 0.05 dose of
these chimeric reaggregates per recipient (after 96 hr ex vivo)
Figure 4. Tracing the Lineage Ancestry of
the Generated HSC Pool
(A) Dissociated cells from the AGM can be manip-
ulated prior to culture. The developmental poten-
tial of CD45+ cells was traced by replacement of
wild-type cells with an EGFP+ counterpart. After
ex vivo development, reaggregates were dissoci-
ated and transplanted into irradiated adult
(Ly5.2/1) recipients along with bone marrow
(Ly5.1/1) carrier cells.
(B) Chimeric reaggregates were constructed by
mixing 135,000 wild-type CD45 cells and 5,000
EGFP+ CD45+ cells and allowed to develop ex
vivo for 96 hr. Shown is a 3D confocal reconstruc-
tion illustrating EGFP+CD45+ cells within the chi-
meric reaggregate (scale bar, 75 mM). (Inset) A
low-magnification EGFP fluorescence/bright-field
overlay (original magnification 603). The vast
majority of the expanded (CD45+) hematopoietic
compartment was found to have derived from
CD45+ ancestry (data are representative of seven
independent experiments).
(C) After 96 hr, 0.05 doses of reaggregate were
transplanted into each irradiated adult recipient.
Lineage ancestry of engrafting cells was resolved
according to EGFP expression. HSCs derived
from CD45+ ancestors were detected in all recipi-
ent animals (data are cumulative of two indepen-
dent experiments).
revealed that no HSCs had been gener-
ated (Figure 6D). In contrast, the input
population of 70 VE-cadherin+CD45+
cells aggregated with WT CD45 cells
had undergone a 240-fold expansion re-
sulting in formation of a pool of 16,850 ±
4,700 CD45+ cells (Figure 6E). Upon
transplantation of a 0.05 dose of reaggre-
gate per recipient, all experimental mice
were reconstituted at a high level (Fig-
ure 6F) and demonstrated myeloid and
lymphoid contribution to all tissues ana-
lyzed (Figure S7). Therefore, pre-HSCs
within the hematopoietic compartment of the E11.5 AGM region
are located within the VE-cadherin+CD45+ population.
DISCUSSION
We have developed an ex vivo model capable of rapidly gener-
ating definitive HSCs from an embryonic organ, which recapit-
ulates the rapid HSC expansion observed within the midgesta-
tion embryo. A short dissociation step and manipulation of cell
subpopulations prior to reconstruction of the functionally active
AGM organoid allowed us to obtain previously unavailable in-
formation on the origin and mechanisms of HSC generation.
These data show that, while the 45-fold expansion of CFU-C
progenitors can be explained by rapid proliferation (five to
seven divisions over 4 days), the process of extensive CFU-S
and HSC formation (230- and 150-fold increase, respectively)104 Cell Stem Cell 3, 99–108, July 2008 ª2008 Elsevier Inc.
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Development of HSCs in the AGM RegionFigure 5. VE-Cadherin and CD45 Coexpressing Cells Are Specifically Associated with the Dorsal Aorta
(A) Transverse section through an E11.5 AGM region showing CD45 (green) and VE-cadherin (red) expression. The boundary of the region is outlined. Note that
CD45-expressing cells are present within the urogenital ridges (UGR) and the area of the dorsal aorta (Ao) and para-aortic mesenchyme. Ventral side is orientated
down (scale bar, 70 mm).
(B) Representative example of VE-cadherin+CD45+ cells integrated into the ventral endothelial lining of the dorsal aorta (scale bar, 30 mm).
(C) Representative example of a ventral intra-aortic hematopoietic cluster composed of VE-cadherin+CD45+ cells (scale bar, 30 mm).
(B0 and C0) Digital zoom of respective boxed regions in (B) and (C) providing a detailed representation of the coexpression of VE-cadherin and CD45 on indicated
cells (arrow; scale bar, 11 mm). DAPI-stained nuclei are shown in blue. Images are representative of the analysis of sequential sections from three individual E11.5
AGM regions.must occur predominantly through a maturation process. By
replacing cell populations with analogous sorted EGFP-positive
fractions, we demonstrated that HSC specification within the
E11.5 AGM region occurs via the acquisition of stem cell func-
tions by CD45+ cells.
Previously, we and others have characterized the CD45+ com-
partment in the E11.5 AGM region and identified two functionally
distinct populations (North et al., 2002; Taoudi et al., 2005). The
major population (VE-cadherinCD45+) predominantly contains
mature hematopoietic cells and a low frequency of progenitor
cells. The second, a rare VE-cadherin+CD45+ population, is en-
riched for blast-like cells and contains a high frequency of hema-
topoietic progenitors. Importantly, the VE-cadherin+CD45+ pop-
ulation also harbors the single definitive HSC detectable in the
E11.5 AGM region.
To determine which of these CD45+ subpopulations matures
into definitive HSCs, we purified them separately from theE11.5 AGM region (from EGFP embryos) and, following coreag-
gregation with wild-type AGM microenvironment, transplanted
small doses of cultured cells into irradiated recipients. While
VE-cadherinCD45+ cells were not able to give rise to HSCs,
the VE-cadherin+CD45+ fraction was highly efficient in producing
definitive HSCs as all transplanted mice were reconstituted.
We found that some VE-cadherin+CD45+ cells have a cuboid
shape and are integrated into the endothelial lining of the dorsal
aorta. Rare solitary VE-cadherin+CD45+ cells are also found on
the luminal surface of the dorsal aorta. However, the vast major-
ity of the VE-cadherin+CD45+ cells in the AGM region are
organized as intra-aortic clusters.
If the formation of HSCs occurs via ‘‘budding’’ from the endo-
thelial lining, as has been previously speculated (Dzierzak and
Speck, 2008), this may be initiated via upregulation of CD45 in
emerging pre-HSCs within the endothelial layer (specification
of pre-HSCs), as illustrated in Figure 7. Alternatively, theCell Stem Cell 3, 99–108, July 2008 ª2008 Elsevier Inc. 105
Cell Stem Cell
Development of HSCs in the AGM RegionFigure 6. Pre-HSCs in the E11.5 AGM
Region Are Identified by the VE-Cadher-
in+CD45+ Immunophenotype
(A) Representative example of sort criteria and pu-
rity checks used to purify VE-cadherin+CD45+ and
VE-cadherinCD45+ populations from the fresh
EGFP+ E11.5 AGM regions.
(B) Representative example of CD45 cells puri-
fied from fresh wild-type (WT) E11.5 AGM regions.
(C) AGM chimeric reaggregates were generated
from 5,000 EGFP+ VE-cadherinCD45+ and
135,000 WT CD45 cells and cultured for 96 hr.
Shown is an example of such a reaggregate
(EGFP fluorescence/bright-field merge, original
magnification 503) and the numbers of EGFP+
CD45+ cells before (0 hrs) and after ex vivo devel-
opment (96 hrs) (two independent experiments ±
SEM).
(D) After 96 hr, a 0.05 dose of reaggregate was
transplanted into each recipient mouse; 0 out of
12 were reconstituted.
(E) Chimeric reaggregates were generated from
purified 70 EGFP+ VE-cadherin+CD45+ cells and
135,000 WT CD45 cells. Shown is an example
of such a reaggregate (EGFP fluorescence/
bright-field merge, original magnification 503)
and the numbers of EGFP+CD45+ cells before
(0 hrs) and after ex vivo development (96 hrs)
(two independent experiments ± SEM).
(F) Following transplantation of a 0.05 dose of
reaggregate per recipient, all nine out of nine
mice were reconstituted at a high level.incorporation of an external specialized precursor, e.g., from
subendothelial mesenchyme, into the endothelial layer cannot
be ruled out (Bertrand et al., 2005; North et al., 2002). Further
invagination of the endothelial lining results in formation of the
epithelial-like buds (concomitant with formation of characteristic
indentation of the endothelial lining) containing expanded VE-
cadherin+CD45+ pre-HSCs that are not yet functional definitive
HSCs. Further studies to directly investigate the source of pre-
HSCs will be needed to substantiate this model.
It will be one of the key future challenges to understand the
cascade of molecular events leading initially to specification of
the pre-HSC and the subsequent formation of definitive HSCs.
The culture system described here provides a powerful tractable
resource for further analysis of cellular compartments constitut-
ing complex HSC niches and the molecular networks underlying
the specification and expansion of definitive HSCs.
EXPERIMENTAL PROCEDURES
Mice
Mice were housed and bred in animal facilities at the University of Edinburgh in
compliance with Home Office regulations. Embryos were generated from the
pairing of either C57BL/6 or C57BL/6 aEGFP females (Gilchrist et al., 2003)
with CBA or C57BL/6 stud males. The morning after discovering a vaginal
plug was designated as day 0.5. The developmental stage of embryos was
determined according to Theiler’s criteria.106 Cell Stem Cell 3, 99–108, July 2008 ª2008 Elsevier Inc.Tissue Culture
E11.5 AGM regions were dissected and dissociated as previously described
(Kumaravelu et al., 2002).
Organ Explant
Whole AGM regions were cultured as previously described, except steel
meshes were not used and organs were cultured in IMDM+ medium (IMDM
[Invitrogen], 20% fetal calf serum, L-glutamine [4 mM], penicillin/streptomycin
[50 units/ml], mercaptoethanol [0.1 mM], IL-3 [100 ng/ml], SCF [100 ng/ml],
and Flt3L [100 ng/ml]; growth factors were purchased from Peprotech).
Tissues were maintained in 5% CO2 at 37
C in a humidified incubator.
Submersion Culture
In 250 ml IMDM+, one equivalent of dissociated AGM cells was cultured in U- or
V-bottom 96-well tissue culture plates (Bibby Sterilin).
Reaggregation Technique
Dissociated cells were resuspended in 10 ml of IMDM+ per one AGM equiva-
lent. Reaggregates (one embryo equivalent per reaggregate) were made by
centrifugation in a yellow tip occluded by parafilm at 300 3 g for 5 min and
cultured on the top of a 0.65 mm Durapore filter (Millipore, Cat. No.
DVPP02500) at the gas-liquid interface. This technique in application to the
thymus is described in J.S. et al., unpublished data.
CFU-C Assay
Colony development was performed using M3434 medium (StemCell Technol-
ogies) according to the manufacturer’s instructions. Colonies were scored
after 7–9 days.
Long-Term Repopulation Assay
Donor tissues from Ly5.2/2 embryos were isolated, cultured, and transplanted
into irradiated Ly5.2/1 adult recipients as described previously (Kumaravelu
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out the article in doses and defined as a unit of cells equivalent to their number
present in one cultured organ; for example, a 0.05 dose is equal to 5% of the
cells present in one cultured organ. Donor cells were coinjected with 20,000
Ly5.1/1 bone marrow cells. Donor chimerism was determined as described
previously (Taoudi and Medvinsky, 2007).
Phenotypic Identification of HSCs
Cellular suspensions were stained with the appropriate combination using the
following monoclonal antibodies: anti-CD45, anti-PECAM-1, anti-Sca1, anti-
cKit, and anti-CD34. Donor contribution was assessed by flow cytometry
using anti-Ly5.2-PE and anti-Ly5.1-APC antibodies (BD Biosciences). Mice
demonstrating R5% donor-derived chimerism (contributing to both myeloid
and lymphoid lineages) after a minimum of 16 weeks were considered to be
reconstituted. Limiting dilution analysis was performed using L-Calc software
(Stem Cell Technologies).
CFU-S Assay
Cells were transplanted into irradiated adult mice. After 11 days, recipient
spleens were dissected, fixed in Bouin’s solution, and macroscopic colonies
counted. When using EGFP+ donor tissues, spleens were directly examined
without fixation. Images were captured using a MZFLIII dissecting microscope
(Leica).
Figure 7. Proposed Model for the Development of Pre-HSCs within
Intra-Aortic Clusters
(A) Specification of a VE-cadherin+CD45+ (double-positive, DP) cell by upregu-
lation of CD45 in the endothelial lining (scenario I). It cannot be ruled out that,
alternatively, an external precursor (e.g., from subendothelial mesenchyme)
integrates into the endothelial lining (scenario II).
(B) Initiation of the invagination of the endothelial layer led by DP cells (hema-
topoietic by nature) is accompanied by formation of a characteristic indenta-
tion of the lining (also see Figure 5).
(C) Formation of the epithelial-like ‘‘bud’’ formed mainly by the DP population
enriched for pre-HSCs. The vast majority of DP cells in E11.5 AGM region
are organized in clusters (two to four clusters per E11.5 AGM region). Red,
localization of VE-cadherin; green, localization of CD45. Colocalization of
VE-cadherin and CD45 is indicated by red-green dotted line.Cell Cycle Analysis
Cell cycle analysis was performed using the BrdU Flow Kit (BD Bioscience). In
brief, reaggregates were removed from filters and submersed in IMDM+ me-
dium containing 10 mM BrdU for 30 min at 37C. Reaggregates were then
washed and dissociated. After staining with anti-CD45 and anti-PECAM-1
antibodies, cells were fixed and processed according to the manufacturer’s in-
structions. Dead cells and debris were excluded on the basis of scatter profile.
Data were acquired using a FACScalibur (BD Biosciences) and analyzed using
FlowJo software (TreeStar).
Carboxyfluorescein Diacetate Succinimidyl Ester Pulse/Chase
CFSE (Invitrogen) was stored as a 5 mM solution in DMSO at 20C. Cellular
suspension from E11.5 AGM was loaded with CFSE as follows: cells from the
E11.5 AGM region (13 106 cells per ml) were incubated in 10 mM CFSE, diluted
in 7% FCS/PBS (Mg2+Ca2+ free) for 10 min at 37C. Reaction volume was
made up to 5.0 ml with ice-cold 10% FSC/PBS (Mg2+Ca2+ free) and incubated
on ice for 5 min. Cells were centrifuged for 5 min at 300 3 g, resuspended in
1.0 ml, and recentrifuged. Reaggregates were produced and maintained as
described above. Dead cells and debris were excluded on the basis of scatter
profile. CFSE content in viable cells was detected using a FACScalibur.
Cytological Examination
Following purification, cells were processed as previously described (Taoudi
et al., 2005).
Confocal Microscopy
Tissues were embedded in O.C.T. by flash-freezing samples on dry ice. 10 mM
sections were produced using a CM1900 cryostat (Leica). Three-dimensional
reconstructions were processed as previously described (Taoudi and Medvin-
sky, 2007). Images were captured using an upright confocal microscope
(DM IRE2, Leica) and processed using Abode Photoshop CS2. The following
antibodies were used: anti-VE-cadherin-Alexa647, anti-CD45-APC/biotin/
purified, anti-PECAM-1-PE, and anti-Sca1-PE. Either anti-rat Alexa488 or
Alexa647 conjugated streptavidin (Molecular Probes, Invitrogen) was used to
detect primary antibodies. Antibodies were purchased from either BD Biosci-
ences or eBioscience.
Lineage-Tracing Experiments
AGM regions were dissected from either wild-type or EGFP mouse lines and
cellular suspensions produced. Cell suspensions were stained with anti-
CD45-biotin antibodies for 20 min in the dark on ice. Cells were then labeled
within streptavidin-conjugated magnetic beads (MiltenyiBiotec); CD45+ and
CD45 fractions were separated by MACS (MiltenyiBiotec) according to man-
ufacturer’s instructions. Purity checks were performed on aliquots from the
collected samples following restaining with streptavidin-conjugated APC
and anti-CD45-APC. Approximately one equivalent of E11.5 AGM cells was re-
aggregated and cultured. For VE-cadherin/CD45 lineage-tracing experiments,
cells from EGFP embryos were purified by flow cytometry (MoFlo, DacoCyto-
mation), as previously described (Taoudi et al., 2005), and then reaggregated
with MACS-purified WT CD45 cells. Experiments were set up in either dupli-
cate or triplicate.
SUPPLEMENTAL DATA
Supplemental Data for this article, including Supplemental Figures, can be
found online at http://www.cellstemcell.com/cgi/content/full/3/1/99/DC1/.
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